This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hermann, L. L.
Right arrow Articles by Coombs, K. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hermann, L. L.
Right arrow Articles by Coombs, K. M.

 Previous Article  |  Next Article 

Journal of Virology, June 2004, p. 6171-6179, Vol. 78, No. 12
0022-538X/04/$08.00+0     DOI: 10.1128/JVI.78.12.6171-6179.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Inhibition of Reovirus by Mycophenolic Acid Is Associated with the M1 Genome Segment

Laura L. Hermann and Kevin M. Coombs*

Department of Medical Microbiology and Infectious Diseases and Department of Physiology, University of Manitoba, Winnipeg, Manitoba, Canada R3E 0W3

Received 20 November 2003/ Accepted 12 February 2004

Mycophenolic acid (MPA), an inhibitor of IMP dehydrogenase, inhibits reovirus replication and viral RNA and protein production. In mouse L929 cells, antiviral effects were greatest at 30 µg of MPA/ml. At this dosage, MPA inhibited replication of reovirus strain T3D more than 1,000-fold and inhibited replication of reovirus strain T1L nearly 100-fold, compared to non-drug-treated controls. Genetic reassortant analysis indicated the primary determinant of strain-specific differences in sensitivity to MPA mapped to the viral M1 genome segment, which encodes the minor core protein µ2. MPA also inhibited replication of both strains of reovirus in a variety of other cell lines, including Vero monkey kidney and U373 human astrocytoma cells. Addition of exogenous guanosine to MPA-treated reovirus-infected cells restored viral replicative capacity to nearly normal levels. These results suggest the µ2 protein is involved in the uptake and processing of GTP in viral transcription in infected cells and strengthens the evidence that the µ2 protein can function as an NTPase and is likely a transcriptase cofactor.

* Corresponding author. Mailing address: Department of Medical Microbiology and Infectious Diseases, University of Manitoba, 730 William Ave., Winnipeg, Manitoba, Canada R3E 0W3. Phone: (204) 789-3309. Fax: (204) 789-3926. E-mail: kcoombs{at}ms.umanitoba.ca.

Journal of Virology, June 2004, p. 6171-6179, Vol. 78, No. 12
0022-538X/04/$08.00+0     DOI: 10.1128/JVI.78.12.6171-6179.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Deng, L., Dai, P., Ciro, A., Smee, D. F., Djaballah, H., Shuman, S. (2007). Identification of Novel Antipoxviral Agents: Mitoxantrone Inhibits Vaccinia Virus Replication by Blocking Virion Assembly. J. Virol. 81: 13392-13402 [Abstract] [Full Text]  


Copyright © 2010 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»